4//SEC Filing
SYNAGEVA BIOPHARMA CORP 4
Accession 0001144204-15-038750
CIK 0000911326operating
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 5:43 PM ET
Size
5.3 KB
Accession
0001144204-15-038750
Insider Transaction Report
Form 4
Biggar Stephen R
Director
Transactions
- Disposition to Issuer
Common Stock
2015-06-22−102→ 0 total
Footnotes (1)
- [F1]Disposition of securities directly held by Stephen R. Biggar, an employee of Baker Bros. Advisors LP in connection with completion of the acquisition of Synageva Biopharma Corp. (the "Issuer") by Alexion Pharmaceuticals, Inc. pursuant to the Agreement and Plan of Reorganization (the "Merger Agreement") dated May 5, 2015, by and among Alexion Pharmaceuticals, Inc., the Issuer, Merger Sub Inc. and Galaxy Merger Sub LLC. Pursuant to the Merger Agreement the Issuer's common shares were exchanged for $115 in cash and 0.6581 share of Alexion Pharmaceuticals, Inc. common stock.
Documents
Issuer
SYNAGEVA BIOPHARMA CORP
CIK 0000911326
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000911326
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 5:43 PM ET
- Size
- 5.3 KB